The case was seen as a test of a more aggressive policy by the agency.
Related Posts
Danaher’s $9.9 Billion Masimo Acquisition Signals Consolidation in Patient Monitoring Technology
null Danaher Corporation has agreed to acquire Masimo Corporation for $180 per share in an all-cash transaction valued at approximately $9.9 billion, marking a significant consolidation move in the...
Humana Nears $1 Billion Acquisition of MaxHealth, Targets Florida Primary Care Expansion
Humana Inc. is in advanced talks to acquire Sarasota, Florida-based MaxHealth, a primary care network, in a deal approaching $1 billion, according to Bloomberg reports. The transaction underscores...
Eli Lilly Bets $2.4 Billion on Orna Therapeutics to Advance In Vivo Cell Therapies
Eli Lilly agreed to acquire Orna Therapeutics for up to $2.4 billion in cash, securing access to proprietary circular RNA technology for in vivo cell engineering in autoimmune diseases and oncology....
Novartis Doubles Down on Early-Stage M&A Strategy as Near-Launch Assets Become Scarce
null Novartis is reinforcing its commitment to acquiring early-stage pipeline assets and clinical-stage candidates, even as the pharmaceutical giant faces intensifying competition for late-stage drug...